HCC Pharm ApS

CVR number: 41029013
Linien 18 A, 5683 Haarby

Income statement (kDKK)

2020202120222023
Fiscal period length12121212
Net sales
Gross profit-63.4518.3829.0228.33
Total depreciation-24.20-24.20-24.20-24.20
EBIT-87.65-5.824.814.13
Other financial income0.02
Other financial expenses-0.02-18.86-18.30-18.40
Pre-tax profit-87.65-24.68-13.49-14.27
Income taxes10.00
Net earnings-87.65-24.68-13.49-4.27

Assets (kDKK)

2020202120222023
Intangible assets total
Land and waters559.39535.19510.99486.78
Tangible assets total559.39535.19510.99486.78
Investments total
Long term receivables total
Inventories total
Current trade debtors44.9045.10
Current other receivables8.25
Current deferred tax assets10.00
Short term receivables total44.9063.34
Balance sheet total (assets)559.39535.19555.89550.13

Equity and liabilities (kDKK)

2020202120222023
Share capital40.0040.0040.0040.00
Retained earnings-87.65- 112.32- 125.81
Profit of the financial year-87.65-24.68-13.49-4.27
Shareholders equity total-47.65-72.33-85.81-90.09
Non-current owed to group member610.08610.08
Non-current other liabilities569.76
Non-current liabilities total569.76610.08610.08
Current loans from credit institutions15.00
Current trade creditors24.5415.0015.0030.00
Current owed to participating574.327.750.14
Current owed to group member8.19
Other non-interest bearing current liabilities16.62
Current liabilities total607.0437.7531.6230.14
Balance sheet total (liabilities)559.39535.19555.89550.13
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.